Novel method for the identification of circulating SARS-CoV-2 variants and clinical characteristics of patient infection with SARS-CoV-2 variants in Central China
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1605198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Youhua Yuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
We established a reliable and cost-effective method for identifying severe acute respiratory syndrome coronavirus 2 variants circulating in central China and analysed the clinical characteristics of patients with acute coronavirus disease 2019 who were infected with these variants.
Methods
The RNA of centrifuged and enriched samples was extracted and reverse transcribed into cDNA. cDNA was then analysed using a nested polymerase chain reaction amplification and Sanger sequencing method targeting specific mutations in the spike, ORF1a , and N genes. This was validated against next-generation sequencing, achieving 100% concordance.
Results
Among 172 isolates, JN.1.18.2 was the most prevalent (52.9%, 91/172), followed by XDV.1 (25.0%, 43/172), JN.1.16 (20.9%, 36/172), and KP.2 (1.2%, 2/172), which was found in central China for the first time. Fever with cough (52.6%, 80/152) was the most common symptom and 59.9% (91/152) of patients had underlying conditions. JN.1.18.2-infected patients more frequently presented with double-lung computed tomography changes. A strong positive correlation was observed between the duration from hospital admission to the detection of SARS-CoV-2 variants and total hospitalisation duration.
Discussion
The new method provides a reliable tool for variant detection, highlighting milder clinical presentations in patients with active infections. Long-term monitoring of variants and patient characteristics is essential for effective prevention and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
- Department of Laboratory, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Laboratory, People's Hospital of Henan University, Zhengzhou, Henan, China.
- Department of Laboratory, Xinyang Municipal Central Hospital, Xinyang, Henan, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yuan, Y., Geng, Y., Rong, T., Wang, B., Mao, X., Zhang, X., Zhang, X., Zhang, Y., Zheng, P., Zhao, J., & Guo, F. (2025). Novel method for the identification of circulating SARS-CoV-2 variants and clinical characteristics of patient infection with SARS-CoV-2 variants in Central China. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1605198
Vancouver
Yuan Y, Geng Y, Rong T, Wang B, Mao X, Zhang X, et al. Novel method for the identification of circulating SARS-CoV-2 variants and clinical characteristics of patient infection with SARS-CoV-2 variants in Central China. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1605198
BibTeX
@article{Yuan2025,
author = {Yuan, Youhua and Geng, Yiman and Rong, Tingjun and Wang, Baoya and Mao, Xiaohuan and Zhang, Xiaohuan and Zhang, Xiulei and Zhang, Yuan and Zheng, Peiming and Zhao, Jing and Guo, Fengxia},
title = {Novel method for the identification of circulating SARS-CoV-2 variants and clinical characteristics of patient infection with SARS-CoV-2 variants in Central China},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1605198}
}
EUVIMED